share

Dr. Derek Jones - Dermatology Research in Los Angeles

Due to his extensive experience researching in the field of cosmetic and general dermatology, Dermatologist Dr. Derek Jones is one of the most sought-after researchers to perform FDA trials on newer noninvasive cosmetic technologies. He has served as a Principal Investigator on many clinical trials in facial aesthetics that lead to the approval of JUVEDERM®, JUVEDERM® ULTRA PLUS, BELOTERO®, LATISSE® and XEOMIN®. He was also Lead Investigator on the FDA study for Kybella and JUVEDERM VOLUMA. In addition, Dr. Jones has conducted investigations into the cosmetic effects of a number of botulinum toxins, including BOTOX® Cosmetic.

To learn more about Dr. Jones' work or to request an appointment with him, contact Skincare and Laser Physicians of Beverly Hills online or by phone at 310-246-0495.

He has a state-of-the-art facility dedicated to clinical trials and research. Dr. Jones has written more than 100 peer-reviewed articles and has presented more than 300 scholarly lectures on the research findings at professional meeting around the globe. He is currently testing the latest generation of muscle relaxant toxins, dermal fillers, and lasers with more than 100 patients enrolled in the studies. His team works diligently from Beverly Hills to remain at the forefront of research and technology.

Leading the Curve of Innovation:
Dr. Jones and his physician
associates have pioneered research
that lead directly to
U.S. market approval
of today's most popular injectables
including Botox®, Voluma®,
Juvederm®, Kybella®, Belotero®,
and many more.

Dr. Derek Jones is a Pioneer in His Field

If you are ready to schedule a consultation with Dr. Jones for the treatment of your choice, you can request a consultation with us online or call our office at 310-246-0495 for more information.

  1. Lead Investigator, Investigator for FDA approval on VOLUMA for treatment of age related midface lipoatrophy. Allergan. 2007-2013.
  2. Lead Investigator, Phase 3 study of KYBELLA (sodium deoxycholate injection) versus placebo for the reduction of localized subcutaneous fat in the submental area. Kythera. 2012-2014
  3. Lead Investigator, Investigator Initiated Trial on Combination of Botox Cosmetic and Juvederm Ultra for Brow Enhancement. 2010-2011.
  4. Principal Investigator, Investigator for FDA approval on a new family of Juvederm. Allergan. 2004-2006
  5. Principal Investigator, Investigator for FDA approval on BELOTERO Soft for treatment of mild nasolabial folds. Merz Pharmaceuticals 2008
  6. Principal Investigator, Investigator for FDA approval on a new hyaluronic acid filler BELOTERO. Merz Pharmaceuticals. 2006-2008
  7. Principal Investigator, Investigator for FDA approval on XEOMIN for treatment of glabellar furrows. Merz Pharmaceuticals. 2008-2011.
  8. Principal Investigator, Study to investigate the equivalence of Xeomin to Botox in the treatment of glabellar frown lines. Merz Pharmaceuticals. 2013-2014
  9. Principal Investigator, Study of ATX-101 for the reduction of localized subcutaneous fat in the submental area in subjects with clinician reported submental fat rating scale grade 1 or grade 4. Kythera. 2013-2015
  10. Principal Investigator, FDA approval on Latisse solution for eyelash growth. Allergan. 2007-2008
  11. Principal Investigator, FDA approval for Juvederm for perioral and lip rejuvenation. Allergan. 2007-2008
  12. Principle Investigator, FDA approval of Restylane Refyne. Galderma. 2010.
  13. Principle Investigator, Study of LIPO-202 (salmeterol xinafoate (SX)) versus placebo for the reduction of localized subcutaneous fat in the abdomen area. Lithera. 2013-2014
  14. Principal Investigator, Study of Latisse versus placebo for eyebrow growth. Allergan. 2013-2014
  15. Principal Investigator, Study of efficacy of DWP-450 for treatment of moderate-to-severe glabellar lines. Evolus. June 2014-September 2016
  16. Principal Investigator, Study of DWP-450 for treatment of moderate-to-severe glabellar lines. Evolus. June 2014-October 2016
  17. Principal Investigator, Post approval study of Radiesse for the Treatments of Hands with Moderate to Very Severe Dorsal Volume Loss. Merz Pharmaceuticals. February 2016-Present
  18. Principal Investigator, Randomized Double-Blinded, Placebo Controlled, Muli-Center Trial to Evaluate the Safety and Efficacy and Duration of Effect of DaxibotulinumtoxinA for Injections to Treat Moderate to Severe Glabellar Lines. Revance. 2017-2018
  19. Principal Investigator, An Open-Label Multi-Center to Assess the Safety of Single and Repeat Treatments of DaxibotulinumtoxinA for Injection for Treatment of Moderate to Severe Glabellar Lines. Revance. 2017-2018
  20. Principal Investigator, A Multicenter, Open-Label, Prospective Study of Cannula Injection of Restylane Lyft with Lidocaine for Cheek Augmentation and the Correction of Age Related Midface Contour Deficiencies. Galderma. 2017
  21. Principal Investigator, A Multicenter, Single-Blind, Randomized, Controlled Study of the Safety and Effectiveness of JUVEDERM VOLUMA XC Injectable Gel for Cheek Augmentation using Cannula. Allergan 2018
  22. Investigator, Pre-market study of the clinical utility and applications of computerized, digital microscopy in the detection of malignant melanoma. Rodenstock, Inc. 2000-2001
  23. Principal Investigator, Abgenix and Quintiles: Protocol ABX-0204: Part II. A two part, multi-center, randomized, double-blind, placebo controlled, multiple dose clinical trial of ABX-IL8 (a monoclonal antibody IL-8 inhibitor) in patients with moderate to severe plaque psoriasis. 2001-2002
  24. Principal Investigator, A Multi-Center, Double-Blind Placebo Controlled, Parallel Group Study Comparing Bioequivalence 2 Formulations of Metronidazole Gel 0.075% for Rosacea. TEVA Pharmaceuticals. 2001-2002
  25. Investigator, FDA study investigator for SilSkin (highly purified 1000 cs silicone oil) in treating nasolabial folds, mid-malar depressions, oral commissures, and HIV associated facial lipoatrophy. RJ Development, Peabody, MA. 2001

If you are ready to schedule a consultation with Dr. Jones for the treatment of your choice, you can request a consultation with us online or call our office at 310-246-0495 for more information.

 

"WE ARE A PHYSICIAN ONLY PRACTICE OPERATING AT THE FOREFRONT OF AESTHETIC DERMATOLOGY"

  I accept the Terms of Use

 Send promotions

security code

Video Gallery

Get a quick look at why SCLS is so unique.

VIEW VIDEOS

Reduce Unwanted Fat